Vaxart VXRT
OTC VXRT
$0.48 -0.01 (-2.04%)
At close: Oct 21, 2026 · 4:00 PM EDT

Vaxart (VXRT) Operating Expenses (2010 - 2026)

Updated

Vaxart (VXRT) recorded Operating Expenses of $40.36 million in Q2 2026, down 25.7% from $54.33 million a year earlier but up 18.5% from the prior quarter.

Analysis

Vaxart (VXRT) Operating Expenses (2010 - 2026) Analysis & Trends

On a TTM basis, Vaxart's Operating Expenses came in at $203.45 million as of Jun 30, 2026, up 49.3% year-over-year; for FY2025, it came in at $219.18 million, up 130.7% from FY2024.

  • Annual Operating Expenses has a five-year compound annual growth rate of 45.0% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $94.99 million in FY2024 (+4.7%), $90.73 million in FY2023 (-20.9%), $114.69 million in FY2022 (+55.7%) and $73.64 million in FY2021 (+115.2%).
  • Quarterly Operating Expenses has ranged from $17.45 million in Q3 2021 to $80.22 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Operating Expenses rose in five of the last eight quarters, with growth averaging 71.5%.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 313.4% in Q3 2025, against a decline of 35.3% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $34.05 million (Q1 2026), $48.82 million (Q4 2025) and $80.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,171.69 Bn 1,140.28 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 649.22 Bn 569.08 Bn 17.30 Bn 11.12 Bn
3 AbbVie 504.17 Bn 477.29 Bn 12.70 Bn 10.56 Bn
4 Merck 366.35 Bn 320.73 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 303.54 Bn 267.53 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 269.49 Bn 243.18 Bn 12.86 Bn 9.70 Bn
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 195.09 Bn 169.29 Bn 6.22 Bn 18.20 Bn
9 Pfizer 172.48 Bn 119.12 Bn 10.94 Bn 6.68 Bn
10 Vaxart 106.79 Mn 42.79 Mn - 40.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.36 Mn
Mar 31, 2026 34.05 Mn
Dec 31, 2025 48.82 Mn
Sep 30, 2025 80.22 Mn
Jun 30, 2025 54.33 Mn
Mar 31, 2025 35.81 Mn
Dec 31, 2024 26.68 Mn
Sep 30, 2024 19.41 Mn
Jun 30, 2024 22.66 Mn
Mar 31, 2024 26.25 Mn
Dec 31, 2023 20.15 Mn
Sep 30, 2023 19.92 Mn
Jun 30, 2023 24.41 Mn
Mar 31, 2023 26.25 Mn
Dec 31, 2022 31.16 Mn
Sep 30, 2022 29.43 Mn
Jun 30, 2022 29.25 Mn
Mar 31, 2022 24.86 Mn
Dec 31, 2021 24.29 Mn
Sep 30, 2021 17.45 Mn
API Access

Vaxart Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=VXRT&period=max&api_key=YOUR_API_KEY